Daewoong Pharmaceutical Co., Ltd (KRX:069620)
South Korea · Delayed Price · Currency is KRW 100,400
+1,300 (1.31%)
Oct 28, 2026, 2:50 PM KST
Daewoong Pharmaceutical Market Cap
Daewoong Pharmaceutical has a market cap or net worth of 1.16 trillion as of October 27, 2026. It is the 10,799th most valuable company in the world and the 270th biggest in South Korea. Its market cap has decreased by 28.34% in one year.
Market Cap
1.16T
Enterprise Value
2.05T
Revenue
1.64T
Global Rank
Country Rank
#270 South Korea
PE Ratio
5.91
ChartMarket Cap Chart
Since March 12, 2003, Daewoong Pharmaceutical's market cap has increased from 131.88B to 1.16T, an increase of 775.98%. That is a compound annual growth rate of 9.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 1.16T | -41.73% |
| Dec 30, 2025 | 1.98T | 36.31% |
| Dec 30, 2024 | 1.45T | 8.22% |
| Dec 28, 2023 | 1.34T | -23.40% |
| Dec 29, 2022 | 1.75T | 7.09% |
| Dec 30, 2021 | 1.64T | -7.75% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hanall Biopharma | 1.96T |
| Celltrion Pharm | 1.61T |
| GC Biopharma | 1.48T |
| Chong Kun Dang Pharmaceutical | 815.60B |
| Boryung | 698.25B |
| Daewoong | 609.96B |
| Dong-A Pharmaceutical | 591.55B |
| JW Pharmaceutical | 527.96B |